Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07526649 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b)

Study acronym: COOLHEAD-2B
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
COOLHEAD-2b is a multicentre, phase 2, prospective, randomised, controlled, open-label, blinded-endpoint trial evaluating the safety and efficacy of non-invasive convective head cooling as an adjunct to endovascular thrombectomy (EVT) in patients with acute anterior circulation ischaemic stroke. Head cooling is initiated as early as possible, including during inter-hospital transfer, and continued until one hour after reperfusion. The primary efficacy endpoint is final infarct volume at 24 hours.
Trial Details
NCT Number NCT07526649
Lead Sponsor Auckland City Hospital
Collaborators: Neurological Foundation of New Zealand, Health New Zealand
Conditions
(from sponsor)		 Stroke, Acute Ischemic Stroke, Brain Ischemia, Ischaemic Stroke, Thrombectomy, Endovascular Procedures, Reperfusion Injury, Cooling +1 more
Related terms Brain Ischemia, Ischemic Stroke, Reperfusion Injury, Stroke
Enrollment 182 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov